Nick Pizzie

Insider Reports History

Entity
Individual
Location
25 Broadway, 9 Th Floor, New York, NY
Signature
/s/ Nick Pizzie
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nick Pizzie:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Axsome Therapeutics, Inc. Chief Financial Officer Common Stock 42.2K $5.53M $131.07 Feb 14, 2025 Direct
Axsome Therapeutics, Inc. Chief Financial Officer Performance Stock Units 9.42K $1.24M $131.07 Feb 24, 2025 Direct
Axsome Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 9.42K $1.24M $131.07 Feb 21, 2025 Direct
Axsome Therapeutics, Inc. Chief Financial Officer Common Stock 488 $64K $131.07 Feb 13, 2025 Indirect
Axsome Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 0 $0 $3.50 Feb 14, 2025 Direct
Axsome Therapeutics, Inc. Chief Financial Officer Employee Stock Option (Right to Buy) 9.52K Feb 21, 2025 Direct

Insider Reports Filed by Nick Pizzie

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AXSM Axsome Therapeutics, Inc. Feb 21, 2025 3 $0 4 Feb 25, 2025 Chief Financial Officer
AXSM Axsome Therapeutics, Inc. Feb 13, 2025 6 -$1.95M 4 Feb 14, 2025 Chief Financial Officer
AXSM Axsome Therapeutics, Inc. Feb 27, 2024 2 $0 4 Feb 29, 2024 CHIEF FINANCIAL OFFICER
AXSM Axsome Therapeutics, Inc. Mar 2, 2023 2 $0 4 Mar 6, 2023 CHIEF FINANCIAL OFFICER
AXSM Axsome Therapeutics, Inc. Mar 4, 2022 2 $0 4 Mar 8, 2022 CHIEF FINANCIAL OFFICER
AXSM Axsome Therapeutics, Inc. Nov 18, 2021 4 $33.7K 4 Nov 22, 2021 CHIEF FINANCIAL OFFICER
AXSM Axsome Therapeutics, Inc. Nov 12, 2021 1 $0 4 Nov 15, 2021 CHIEF FINANCIAL OFFICER